跳至主要内容
临床试验/TCTR20200420004
TCTR20200420004
已完成
不适用

Current era survival of treat and repair congenital systemic to pulmonary shunt with borderline pulmonary vascular disease

Faculty of Medicine0 个研究点目标入组 432 人2020年4月20日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Data of outcomes in patients who had PAH-CHD (confirmed by dignostic cardiac catheterization) with borderline pulmonary vascular resistance (PVR) and recieved directed targeted therapy prior to surgic
发起方
Faculty of Medicine
入组人数
432
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2020年4月20日
结束日期
2023年9月30日
最后更新
去年
研究类型
Observational
性别
All

研究者

发起方
Faculty of Medicine

入排标准

入选标准

  • 1\.Patients who underwent cardiac catheterization to assess hemodynamic data or transcatheter closure of the defects in Siriraj Hospital between January 1st, 1995 and December 31st, 2021
  • 2\.All patients who had evidence of PAH\-CHD on the cardiac catheterization including mPAP \>20 mmHg, PAWP \< 15 mmHg and calculated PVR \> 3 WU based on a current definition of PAH
  • 3\.Patients who were classified in Eisenmenger syndrome and PAH\-CHD with prevalent left to right shunt

排除标准

  • 1\.Patients who had age \< 3 months,
  • 2\.Patients with single ventricle following surgery
  • 3\.Patients who were classified in PAH with small defect and PAH following defect correction

结局指标

主要结局

未指定

相似试验